J8515 HCPCS Level II code: Cabergoline, oral, 0.25 mg
J8515 is the HCPCS code for “Cabergoline, oral, 0.25 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J8515Cabergoline, oral, 0.25 mg
Short description: Cabergoline, oral 0.25mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J8515 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Non-covered by Medicare
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2006
Where J8515 sits
- 1J codesDrugs administered other than orally
- 2Active code J8515Cabergoline, oral, 0.25 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J8515 mean?
J8515 is the HCPCS code for “Cabergoline, oral, 0.25 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J8515?
CMS lists J8515’s Medicare coverage as “Non-covered by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J8515
All J codesJ7999Compounded drug, not otherwise classifiedJ8498Antiemetic drug, rectal/suppository, not otherwise specifiedJ8499Prescription drug, oral, non chemotherapeutic, nosJ8501Aprepitant, oral, 5 mgJ8502Injection, aprepitant (aponvie), 1 mgJ8510Busulfan; oral, 2 mgJ8520Capecitabine, oral, 150 mgJ8521Capecitabine, oral, 500 mgJ8522Capecitabine, oral, 50 mgJ8530Cyclophosphamide; oral, 25 mgJ8540Dexamethasone, oral, 0.25 mgJ8541Dexamethasone (hemady), oral, 0.25 mg